Cancer: Discrepancies in drug sensitivity

Nature

Volumn 504, Issue 7480, 2013, Pages 381-383

  Weinstein, John N ^a   Lorenzi, Philip L ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ACTIVITY; CANCER CELL CULTURE; CANCER SCREENING; CANCER THERAPY; CELL ASSAY; CELL PROLIFERATION; CELL TYPE; CELL VIABILITY; DATA BASE; DNA FINGERPRINTING; DRUG SENSITIVITY; ENERGY TRANSFER; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE SEQUENCE; HUMAN; NOTE; PRIORITY JOURNAL; PUBLICATION; STANDARDIZATION;

ANTINEOPLASTIC AGENTS; HUMANS; PHARMACOGENETICS;

EID: 84890569671     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature12839     Document Type: Note

References (7)

1. Haibe-Kains, B. et al. Nature 504, 389-393 (2013).
2. Shoemaker, R. H. et al. Prog. Clin. Biol. Res. 276, 265-286 (1988).
3. Weinstein, J. N. et al. Science 275, 343-349 (1997).
4. Barretina, J. et al. Nature 483, 603-607 (2012).
5. Garnett, M. J. et al. Nature 483, 570-575 (2012).
6. The Cancer Genome Atlas Research Network et al. Nature Genet. 45, 1113-1120 (2013).
7. Box, G. E. P. in Robustness in Statistics: Proceedings of a Workshop (eds Launer, R. L. & Wilkinson, G. N. ) 201-236 (Academic, 1979).